Disparities in Receipt of Lymph Node Biopsy Among Early-Stage Female Breast Cancer Patients

被引:24
|
作者
Halpern, Michael T. [1 ]
Chen, Amy Y. [2 ,3 ]
Marlow, Nicole S. [4 ]
Ward, Elizabeth [2 ]
机构
[1] RTI Int, Div Hlth Serv & Social Policy Res, Washington, DC 20005 USA
[2] Amer Canc Soc, Dept Hlth Serv Res, Atlanta, GA 30329 USA
[3] Emory Univ, Dept Otolaryngol, Atlanta, GA 30322 USA
[4] Med Univ S Carolina, Dept Biostat Bioinformat & Epidemiol, Charleston, SC 29425 USA
关键词
AXILLARY DISSECTION; CONSERVING SURGERY; PATTERNS; PREDICTORS; MANAGEMENT; CARCINOMA; OMISSION;
D O I
10.1245/s10434-008-0205-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Accurate staging of early breast cancer requires pathological assessment of axillary lymph node involvement. We evaluated the proportion of women receiving surgery for early-stage breast cancer who do not receive any lymph node biopsy (LNB) and factors associated with not receiving LNB. Patients receiving surgery for early-stage breast cancer (T1a/T1b/T1c/T2N0) during the period 2003-2005 were selected from the National Cancer Database. Patient sociodemographic, clinical, health insurance, and facility information was collected. Logistic regression was used to assess factors predictive of not receiving LNB. The number of women meeting study inclusion criteria was 184,050, 11% of whom did not receive any LNB. Compared with White patients, Black patients had greater likelihood [odds ratio (OR) 1.10, p < 0.001] of receiving no LNB; there were no significant differences for Hispanic or other non-White patients. Individuals who were uninsured (OR 1.24, p < 0.0005) or covered by Medicare at age < 65 years (OR 1.29, p < 0.0001) had greater likelihoods of no LNB compared with those with private insurance. Medicaid patients and Medicare patients a parts per thousand yen65 years were not significantly different from private insurance patients. Compared with the youngest quartile of patients (age a parts per thousand currency sign51 years), patients in the oldest quartile (age a parts per thousand yen73 years) were more than three times as likely (OR 3.30, p < 0.0001) not to receive any LNB. We conclude that, while guidelines indicate that LNB may be considered optional in certain patient groups, it remains a key component in determining stage, and thereby prognosis and appropriate treatment options. These results indicate that significant disparities exist in sampling of axillary lymph nodes among women with early-stage breast cancer.
引用
收藏
页码:562 / 570
页数:9
相关论文
共 50 条
  • [21] Axillary node dissection vs sentinel lymph node biopsy in early-stage breast cancer patients with three positive sentinel lymph nodes
    Huang, Kai
    Misra, Subhasis
    Gabriel, Emmanuel
    Lizarraga, Ingrid
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 1) : 307 - 308
  • [22] Update on sentinel lymph node biopsy for early-stage vulvar cancer
    Slomovitz, Brian M.
    Coleman, Robert L.
    Oonk, Maaike H. M.
    van der Zee, Ate
    Levenback, Charles
    GYNECOLOGIC ONCOLOGY, 2015, 138 (02) : 472 - 477
  • [23] Comment on sentinel lymph node biopsy in early-stage maxillary cancer
    Xiao, Xuan
    Lu, Mengmeng
    Liu, Tingjiao
    Song, Zhifeng
    ORAL ONCOLOGY, 2025, 162
  • [24] Sentinel lymph node biopsy performed with local anesthesia in patients with early-stage breast carcinoma
    Luini, A
    Gatti, G
    Frasson, A
    Naninato, P
    Magalotti, C
    Arnone, P
    Viale, G
    Pruneri, G
    Galimberti, V
    De Cicco, C
    Veronesi, U
    ARCHIVES OF SURGERY, 2002, 137 (10) : 1157 - 1160
  • [25] Treatment implications of a positive sentinel lymph node biopsy for patients with early-stage breast carcinoma
    Chua, B
    Ung, O
    Taylor, R
    Bilous, M
    Salisbury, E
    Boyages, J
    CANCER, 2001, 92 (07) : 1769 - 1774
  • [26] Clinical Practice Status of Sentinel Lymph Node Biopsy for Early-Stage Breast Cancer Patients in China: A Multicenter Study
    Zhang, Juliang
    Wang, Ting
    Yan, Changjiao
    Huang, Meiling
    Fan, Zhimin
    Ling, Rui
    CLINICAL EPIDEMIOLOGY, 2020, 12 : 917 - 924
  • [27] EVALUATION OF SAFETY AND EFFICACY OF THE SENTINEL LYMPH NODE BIOPSY IN PATIENTS WITH EARLY-STAGE BREAST CANCER WITHOUT AXILLARY INVOLVEMENT
    Yalav, Orcun
    Demircan, Orhan
    Sakman, Gurhan
    Eray, Ismail Cem
    Melek, Ergin
    Suzan, Zorludemir
    JOURNAL OF BREAST HEALTH, 2013, 9 (01): : 23 - 28
  • [28] Not Performing a Sentinel Node Biopsy for Older Patients With Early-Stage Invasive Breast Cancer
    Chung, Alice
    Gangi, Alexandra
    Amersi, Farin
    Zhang, Xiao
    Giuliano, Armando
    JAMA SURGERY, 2015, 150 (07) : 683 - 684
  • [29] IS IT TIME TO SWITCH TO INDOCYANINE GREEN FLUORESCENCE FOR SENTINEL LYMPH NODE BIOPSY IN EARLY-STAGE BREAST CANCER?
    Goonawardena, J.
    Yong, C.
    Law, M.
    BREAST, 2020, 50 : 155 - 155
  • [30] A New Technique That Complements Sentinel Lymph Node Biopsy: Lymph Node Dissection Under the Intercostobrachial Nerves in Early-Stage Breast Cancer
    Li, Jianyi
    Jia, Shi
    Zhang, Wenhai
    Zhang, Yang
    Qiu, Fang
    Xue, Jinqi
    Gu, Xi
    CLINICAL BREAST CANCER, 2013, 13 (03) : 212 - 218